Exagen Inc. Common Stock (XGN) Stock Price

XGNStock

$7.60−24.26%52W

Market Cap$184.11M

P/E—

PEG Ratio—

Div yield—

Beta2.15

XGN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)121.99%

Price vs S&P 500 (4W)68.86%

VGM Score54.29

Book Value / Share (Quarterly)$0.50

P/TBV (Annual)0.62x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)13.48%

Cash Flow / Share (Quarterly)$-0.31

Price vs S&P 500 (YTD)13.86%

Gross Margin (TTM)58.64%

Net Profit Margin (TTM)-26.61%

EPS (TTM)$-0.81

10-Day Avg Trading Volume0.36M

EPS Excl Extra (TTM)$-0.81

Revenue Growth (5Y)9.66%

EPS (Annual)$-0.93

ROI (Annual)-45.92%

Gross Margin (Annual)58.28%

Net Profit Margin (5Y Avg)-52.37%

Cash / Share (Quarterly)$1.02

Revenue Growth QoQ (YoY)15.92%

ROA (Last FY)-34.39%

Revenue Growth TTM (YoY)20.83%

EBITD / Share (TTM)$-0.46

ROE (5Y Avg)-104.06%

Operating Margin (TTM)-18.58%

Cash Flow / Share (Annual)$-0.62

P/B Ratio13.03x

P/B Ratio (Quarterly)9.20x

Net Income / Employee (Annual)$-92,400

EV / Revenue (TTM)2.25x

Net Interest Coverage (TTM)-3.94x

ROA (TTM)-33.68%

EPS Incl Extra (Annual)$-0.93

Current Ratio (Annual)3.45x

Quick Ratio (Quarterly)2.75x

3-Month Avg Trading Volume0.40M

52-Week Price Return-24.26%

Revenue / Employee (TTM)$329,300

Tangible BV / Share (Quarterly)$1.62

P/S Ratio (Annual)2.39x

Asset Turnover (Annual)1.15x

52-Week High$12.23

Operating Margin (5Y Avg)-48.09%

EPS Excl Extra (Annual)$-0.93

CapEx CAGR (5Y)6.86%

26-Week Price Return133.23%

Quick Ratio (Annual)3.04x

13-Week Price Return79.16%

Total Debt / Equity (Annual)1.49x

Current Ratio (Quarterly)3.18x

Enterprise Value$160.17M

Revenue / Share Growth (5Y)-1.46%

Asset Turnover (TTM)1.27x

Book Value / Share Growth (5Y)-25.41%

Revenue / Employee (Annual)$308,200

Pretax Margin (Annual)-29.89%

Cash / Share (Annual)$1.41

3-Month Return Std Dev107.81%

Gross Margin (5Y Avg)55.62%

Net Income / Employee (TTM)$-87,600

ROE (Last FY)-114.34%

Net Interest Coverage (Annual)-2.74x

EPS Basic Excl Extra (Annual)$-0.93

P/FCF (TTM)26.04x

Receivables Turnover (TTM)5.33x

Total Debt / Equity (Quarterly)2.09x

EPS Incl Extra (TTM)$-0.81

Receivables Turnover (Annual)7.12x

ROI (TTM)-45.66%

P/S Ratio (TTM)2.24x

Pretax Margin (5Y Avg)-52.38%

Revenue / Share (Annual)$3.09

Tangible BV / Share (Annual)$2.57

Price vs S&P 500 (52W)-42.57%

Year-to-Date Return25.82%

5-Day Price Return16.09%

EPS Normalized (Annual)$-0.93

ROA (5Y Avg)-37.31%

Net Profit Margin (Annual)-29.97%

Month-to-Date Return68.87%

Cash Flow / Share (TTM)$-1.45

EBITD / Share (Annual)$-0.57

Operating Margin (Annual)-21.58%

LT Debt / Equity (Annual)1.28x

ROI (5Y Avg)-47.96%

LT Debt / Equity (Quarterly)1.83x

EPS Basic Excl Extra (TTM)$-0.81

P/TBV (Quarterly)0.96x

P/B Ratio (Annual)7.78x

Pretax Margin (TTM)-26.54%

Book Value / Share (Annual)$0.76

Price vs S&P 500 (13W)76.36%

Beta2.15x

Revenue / Share (TTM)$2.94

ROE (TTM)-121.62%

52-Week Low$2.59

vGradeD

gGradeB

mGradeB

vgmGradeC

XGN Earnings Surprise History

Q2 25-0.18est. -0.15

Q3 25-0.31est. -0.16

Q4 25-0.27est. -0.19

Q1 26-0.20est. -0.25

Q2 26-0.11est. -0.17

XGN Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.18

4.17

Industry Peers — Health Services(30)

Symbol	Value Score	Growth Score	Momentum Score	Price
XGNExagen Inc. Common Stock	D	B	B	$7.60
NTRANatera, Inc. Common Stock	F	A	A	$336.71
LHLabcorp Holdings Inc.	C	D	B	$337.68
DGXQuest Diagnostics Inc.	C	D	B	$244.51
GHGuardant Health, Inc. Common Stock	F	A	A	$164.92
CAICaris Life Sciences, Inc. Common Stock	F	A	B	$28.01
RDNTRadNet, Inc. Common Stock	D	C	C	$76.86
BLLNBillionToOne, Inc. Class A Common Stock	F	F	C	$100.08
CELCCelcuity Inc. Common Stock	—	—	D	$92.27
GRALGRAIL, Inc. Common Stock	D	A	B	$82.54
VCYTVeracyte, Inc.	D	A	C	$44.04
CDNACareDx, Inc.	D	B	A	$50.80
PSNLPersonalis, Inc. Common Stock	F	D	A	$17.25
FTREFortrea Holdings Inc. Common Stock	B	F	A	$18.27
FRNMFreenome, Inc. Common stock	—	F	A	$13.99
LMRILumexa Imaging Holdings, Inc. Common Stock	C	C	B	$12.07
CSTLCastle Biosciences, Inc. Common Stock	D	B	B	$35.00
FLGTFulgent Genetics, Inc. Common Stock	C	D	C	$19.95
YDESYD Bio Limited Ordinary Shares	—	—	D	$4.68
BDSXBiodesix, Inc. Common Stock	D	B	A	$28.07
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares	—	F	B	$11.95
BNRBurning Rock Biotech Limited American Depositary Shares	B	F	D	$9.80
SERASera Prognostics, Inc. Class A Common Stock	D	D	C	$2.18
MDXHMDxHealth SA Ordinary Shares	B	B	F	$0.79
ADVBAdvanced Biomed Inc. Common Stock	A	—	B	$9.18
AMSAmerican Shared Hospital Services	A	C	D	$1.47
ACONAclarion, Inc. Common Stock	—	B	D	$2.49
BGLCBioNexus Gene Lab Corp Common stock	B	F	F	$1.55
ACONWAclarion, Inc. Warrant	—	—	D	$0.03
EXASExact Sciences Corp	F	B	B	$0.00
YDESWYD Bio Limited Warrants	—	—	D	$0.36

About Exagen Inc. Common Stock

Exagen Inc is a commercial-stage diagnostics company offering ten testing solutions under the Avise brand for autoimmune rheumatic diseases (ARDs). The company's products enable community rheumatologists to accurately diagnose and monitor ARD patients while optimizing treatment decisions. Exagen addresses unmet diagnostic needs in a key therapeutic area.